Cargando…

Evidence of Inflammatory System Involvement in Parkinson's Disease

Parkinson's disease (PD) is a chronic neurodegenerative disease underpinned by both genetic and environmental etiologic factors. Recent findings suggest that inflammation may be a pathogenic factor in the onset and progression of both familial and sporadic PD. Understanding the precise role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chao, Yinxia, Wong, Siew Cheng, Tan, Eng King
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094726/ https://www.ncbi.nlm.nih.gov/pubmed/25050341 http://dx.doi.org/10.1155/2014/308654

Ejemplares similares

Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence
por: Peeraully, Tasneem, et al.
Publicado: (2012)

Historical Perspective: Models of Parkinson’s Disease
por: Chia, Shyh Jenn, et al.
Publicado: (2020)

New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease
por: Tan, Jolene Su Yi, et al.
Publicado: (2020)

Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease
por: Chao, Yin-Xia, et al.
Publicado: (2020)

Role of MicroRNAs in Parkinson’s Disease
por: Goh, Suh Yee, et al.
Publicado: (2019)

Corrigendum: Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease
por: Chao, Yin-Xia, et al.
Publicado: (2020)

Mitophagy and reactive oxygen species interplay in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson’s disease patients with type 2 diabetes mellitus
por: Wang, Ting, et al.
Publicado: (2020)

Leucine-Rich Repeat Kinase 2-Linked Parkinson’s Disease: Clinical and Molecular Findings
por: Kumari, Udhaya, et al.
Publicado: (2010)

Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2019)

Role of dopamine in the pathophysiology of Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Immunotherapy trials in Parkinson’s disease: challenges
por: Xiao, Bin, et al.
Publicado: (2023)

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?
por: Wen, Ming-Ching, et al.
Publicado: (2017)

Parkinson’s Disease-Specific Autoantibodies against the Neuroprotective Co-Chaperone STIP1
por: Tan, Jolene Su Yi, et al.
Publicado: (2022)

Cell replacement for Parkinson’s disease: advances and challenges
por: Xiao, Bin, et al.
Publicado: (2023)

Sleep Problems in Parkinson's Disease
por: Hirata, Koichi, et al.
Publicado: (2015)

Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson’s disease (PD)
por: Zhou, Zhi Dong, et al.
Publicado: (2016)

Parkinson’s disease following COVID-19: causal link or chance occurrence?
por: Li, Wei-Shan, et al.
Publicado: (2020)

Targeting the inflammasome in Parkinson’s disease
por: Su, Qi, et al.
Publicado: (2022)

Combination therapy using GDNF and cell transplant in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Parkinson's Disease Caregiver Strain in Singapore
por: Tan, Siok-Bee, et al.
Publicado: (2020)

MDPD: an integrated genetic information resource for Parkinson's disease
por: Tang, Suisheng, et al.
Publicado: (2009)

QEEG indices are associated with inflammatory and metabolic risk factors in Parkinson's disease dementia: An observational study
por: Liu, Hailing, et al.
Publicado: (2022)

Case-control study of hypertension and Parkinson’s disease
por: Ng, Yuen-Fann, et al.
Publicado: (2021)

Inflammatory Bowel Diseases and Parkinson’s Disease
por: Brudek, Tomasz
Publicado: (2019)

Microarray Analysis of the Molecular Mechanism Involved in Parkinson's Disease
por: Tan, Cheng, et al.
Publicado: (2018)

Is Porphyromonas gingivalis involved in Parkinson’s disease?
por: Olsen, Ingar, et al.
Publicado: (2020)

Parkinson's disease: Are gut microbes involved?
por: Omotosho, Abass Olawale, et al.
Publicado: (2023)

Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson’s disease in Drosophila
por: Liu, Wei, et al.
Publicado: (2022)

Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
por: Xiao, Bin, et al.
Publicado: (2016)

Involvement of Atopic Dermatitis in the Development of Systemic Inflammatory Diseases
por: Itamura, Misa, et al.
Publicado: (2022)

Impact of Covid-19 on research and training in Parkinson's disease
por: Wan, Yi-Min, et al.
Publicado: (2022)

Inflammatory Animal Models of Parkinson’s Disease
por: García-Revilla, Juan, et al.
Publicado: (2022)

Deterministic Tractography of the Nigrostriatal-Nigropallidal Pathway in Parkinson’s Disease
por: Tan, Wen-Qi, et al.
Publicado: (2015)

Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson’s Disease: A Perspective on Associated Therapeutic Interventions
por: Behl, Tapan, et al.
Publicado: (2020)

Dietary Antioxidants and Risk of Parkinson's Disease in the Singapore Chinese Health Study
por: Ying, Ariel Fangting, et al.
Publicado: (2020)

Case Control Polysomnographic Studies of Sleep Disorders in Parkinson's Disease
por: Yong, Ming-Hui, et al.
Publicado: (2011)

Microstructural network alterations of olfactory dysfunction in newly diagnosed Parkinson’s disease
por: Wen, Ming-Ching, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fg5dpnu5oeou9ig2o5nssl80gl